33 studies found for:    FMAU
Show Display Options
Rank Status Study
1 Recruiting 18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
Condition: Malignant Neoplasm
Interventions: Radiation: fluorine F 18 d-FMAU;   Procedure: positron emission tomography;   Procedure: computed tomography
2 Terminated ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
Conditions: HBe Negative Chronic Hepatitis B;   Hepatitis B Viral Infection
Interventions: Drug: CLEVUDINE + TENOFOVIR PLACEBO;   Drug: CLEVUDINE IN ASSOCIATION TENOFOVIR;   Drug: TENOFOVIR + CLEVUDINE PLACEBO
3 Unknown  An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Clevudine 30mg;   Drug: Clevudine 20mg+Adefovir dipivoxil 10mg;   Drug: Clevudine 20mg
4 Recruiting A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
Condition: HBeAg(+) Chronic Hepatitis B
Interventions: Drug: Clevudine;   Drug: Clevudine + Peg-interferon
5 Terminated Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
Condition: Hepatitis B
Intervention: Drug: Clevudine
6 Terminated Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201
Condition: Hepatitis B
Intervention: Drug: Clevudine
7 Terminated Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
Condition: Hepatitis B
Intervention: Drug: Clevudine
8 Completed Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV
Condition: Hepatitis B
Interventions: Drug: Clevudine;   Biological: Purified hepatitis B surface antigen
9 Active, not recruiting A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC
Condition: Hepatitis B Associated Hepatocellular Carcinoma
Intervention: Drug: clevudine, Adefovir
10 Active, not recruiting A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Clevudine, Adefovir
11 Completed A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects
Condition: Healthy
Interventions: Drug: Clevudine, Adefovir dipivoxil , Clevudine+Adefovir dipivoxil;   Drug: Clevudine; Adefovir dipivoxil ,Clevudine +Adefovir dipivoxil;   Drug: Clevudine,Adefovir dipivoxil ,Clevudine +Adefovir dipivoxil
12 Terminated Safety and Antiviral Activity Study of Clevudine 30 Mg QD in Patients With HBeAg(-) Chronic HBV
Condition: Hepatitis B
Intervention: Drug: Clevudine
13 Completed Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
Condition: Hepatitis B
Intervention:
14 Recruiting PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
Conditions: HER2-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Other: laboratory biomarker analysis;   Other: pharmacological study;   Other: questionnaire administration;   Radiation: fluorine F 18-clevudine;   Procedure: positron emission tomography/computed tomography
15 Unknown  A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Condition: Hepatitis B
Intervention: Drug: clevudine (drug)
16 Terminated Safety and Antiviral Activity Study of Clevudine 30 Mg QD in Patient With Chronic HBV
Condition: Hepatitis B
Intervention: Drug: clevudine
17 Terminated Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: adefovir;   Drug: clevudine;   Drug: lamivudine
18 Unknown  A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B
Condition: Patients With LC-B
Interventions: Drug: Clevudine;   Drug: Adefovir dipivoxil
19 Completed Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Intervention: Drug: Clevudine
20 Unknown  A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Clevudine;   Drug: Entecavir

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
Indicates status has not been verified in more than two years